EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More

EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More
Bionxt Solutions has achieved a significant regulatory milestone that advances the commercial prospects for its multiple sclerosis treatment. The European…
Read More
Company & Focus: UniQure N.V. is a Dutch-American biotechnology company (NASDAQ: QURE) specializing in gene therapies. It developed the first…
Read More
In October 2025, Insmed Incorporated announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a…
Read More
This approach allows for precise intervention to prevent unwanted side effects without altering the effectiveness of tumor treatment Munjal Acharya…
Read More
– Advertisement – Swedish digital therapy provider Mindler has acquired ieso Digital Health UK, the NHS-focapplyd arm of Cambridge-based ieso.…
Read More
사진 확대 Sbiomedics announced on the 19th that the technology to develop Parkinson’s disease cell therapy, the company’s main pipeline,…
Read More
Sumitomo Corporation (Head Office: Chiyoda-ku, Tokyo; Representative Director, President and Chief Executive Officer: Shingo Ueno) has invested in AiRato Inc.…
Read More
Andrew Joseph covers health, medicine, and the biopharma indusattempt in Europe. You can reach Andrew on Signal at drewqjoseph.45. European…
Read More